0001468991-12-000001.txt : 20121218 0001468991-12-000001.hdr.sgml : 20121218 20121217220205 ACCESSION NUMBER: 0001468991-12-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121218 DATE AS OF CHANGE: 20121217 EFFECTIVENESS DATE: 20121218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genescient Corp CENTRAL INDEX KEY: 0001468991 IRS NUMBER: 205843946 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-188524 FILM NUMBER: 121269932 BUSINESS ADDRESS: STREET 1: 11180 WARNER AVENUE SUITE 165 CITY: FOUNTAIN VALLEY STATE: CA ZIP: 92708 BUSINESS PHONE: 949-273-0773 MAIL ADDRESS: STREET 1: 11180 WARNER AVENUE SUITE 165 CITY: FOUNTAIN VALLEY STATE: CA ZIP: 92708 D 1 primary_doc.xml X0706 D LIVE 0001468991 Genescient Corp 11180 WARNER AVENUE SUITE 165 FOUNTAIN VALLEY CA CALIFORNIA 92708 949-273-0773 CALIFORNIA The Long Tomorrow Corporation Juenix Corp None Corporation true Gregory Benford 84 Harvey Court Irvine CA CALIFORNIA 92617 Executive Officer Director Cristina Rizza 2920 Ocean Boulevard Corona del Mar CA CALIFORNIA 92625 Executive Officer Director Promoter Peter LePort 2920 Ocean Boulevard Corona del Mar CA CALIFORNIA 92625 Director Carlos Balarezo 1450 University Avenue Riverside CA CALIFORNIA 92507 Executive Officer Director Promoter Yaron Brook c/o Ayn Rand Institute 2121 Alton Parkway Suite 250 Irvine CA CALIFORNIA 92606 Director L James cardarella 610 Newport Center Drive Suite 800 Newport Beach CA CALIFORNIA 92660 Director Biotechnology Decline to Disclose 06 false true false true true true false 100000 Carlos Balarezo None None None 1450 University Avenue No F-19 Riverside CA CALIFORNIA 92507 CA CALIFORNIA MD MARYLAND false 1000000 0 1000000 June 29, 2012, $200,000 promissory note to be replaced on or about December 18, 2012, with convertible promissory note. false 0 0 0 70000 true Estimated up to $75,000 to be paid Mr. Balarezo as partial compensation during the next 12 months. false Genescient Corp Carlos Balarezo Carlos Balarezo CEO 2012-12-17